Keywords
- Systemic Lupus Erythematosus
- Recurrent Pregnancy Loss
- Anticardiolipin Antibody
- Heart Valve Disease
- Livedo Reticularis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Khamashta MA, Mackworth Young C. Antiphospholipid (Hughes) syndrome — a treatable cause of recurrent pregnancy loss. Br Med J 1997;314:244.
Harats D, George J, Levy Y, Khamashta MA, Hughes GRV, Shoenfeld Y. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. Q J Med 1999;92:57–59.
8th International Symposium on Antiphospholipid Antibodies, Sapporo, Japan (1998). Lupus 7(suppl 2):1–234.
Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999;42:1309–1311.
Hughes GRV. Hughes syndrome — the syndrome behind the name (otherwise known as antiphospholipid syndrome). Isr Med Ass J 1999;1:100–103.
Wilson WA, Hughes GRV. Aetiology of Jamaican neuropathy. Lancet 1975;i:240.
Hughes GRV. Connective tissue disease and the skin. The 1983 Prosser-White oration. Clin Exp Dermatol 1984;9:535–544.
Hughes GRV. The anticardiolipin syndrome. Clin Exp Rheumatol 1985;3:285.
Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome [abstract]. Br J Rheumatol 1987;26:19.
Mackworth-Young CG, David J, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features in patients with raised anticardiolipin antibodies and no other disorders [abstract]. Br J Rheumatol 1987;26:94.
Derue GJ, Englert HJ, Harris EN, et al. Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynaecol 1985;2:207–209.
Hughes GRV, Asherson RA. Formes atypiques du lupus erythemateux dissemine. In: Crosnier J, Funck-Brentano JL, Brack JF, Grungeld JP, eds. Actualites nephrologiques. Paris: Flammarion Medicine; 1984.
Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV. Cerebral infarction in systemic lupus. Association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47–51.
Mackworth-Young CG, Gharavi AE, Boey ML, Hughes GRV. Portal and pulmonary hypertension in a case of systemic lupus erythematosus: possible relationships with clotting abnormality. Eur J Rheumatol Inflamm 1984;7:72–74.
Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GR. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 1985;44:281–282.
Asherson RA, Hughes GRV. Antiphospholipid antibodies and chorea. J Rheumatol 1988;15:377–379.
Asherson RA, Morgan SH, Harris EN, Gharavi AE, Kraus T, Hughes GRV. Arterial occlusion causing large bowel infarction in SLE. Reflection of clotting diathesis. Clin Rheumatol 1986;5:102–106.
Harris EN, Gharavi AE, Hegde U, et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985;59:231–234.
Asherson RA, Mackworth-Young CG, Boey ML, et al. Pulmonary hypertension in systemic lupus erythematosus. Br Med J 1983;287:1024–1025.
Asherson RA, Mercy D, Philips G, et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann Rheum Dis 1987;46:605–611.
Harris EN, Gharavi AE, Bowie ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in SLE. Lancet 1983;ii:1211–1214.
Harris EN, Gharavi AE, Patel SP, et al. Evaluation of the anticardiolipin antibody test: report of a standardisation workshop held on April 4th, 1986. Clin Exp Immunol 1987;58:215–222.
Harris EN, Englert H, Derue G, et al. Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet 1983;ii:1361–1362.
Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:568–571.
Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541–1544.
Asherson RA, Hughes GRV. Addison’s disease and primary antiphospholipid syndrome. Lancet 1989;ii:874.
Asherson RA, Khamashta MA, Ordi-Ros J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366–374.
Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482–488.
Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin co-factor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177–178.
Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) are directed not to cardiolipinbut to a plasma protein co-factor. Lancet 1990;335:1544–1547.
McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990;87:4120–4124.
Roubey RAS. Auto-antibodies to phospholipid binding proteins: a new view of lupus anticoagulants and other “antiphospholipid” antibodies. Blood 1994;84:2854–2867.
Atsumi T, Khamashta, MA, Amengual, O et al. Binding of anticardiolipin antibodies to Protein C via β 2-glycoprotein I (β 2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the Protein C system. Clin Exp Immunol 1998;112:325–333.
Moore JE, Mohr CF. Biologically false positive serological test for syphilis. Type, incidence and cause. J Am Med Ass 1952;150:467–473.
Laurell AB, Nilsson IM. Hypergammaglobulinaemia, circulating anticoagulant and biological false positive Wasserman reaction: a study of 2 cases. J Lab Clin Med 1957;49:694–707.
Bowie EJW, Thompson JH Jr, Pascuzzi CV, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulant. J Lab Clin Med 1983;62:416–430.
Beaumont JL. Syndrome hemorrhagique acquis du a un anticoagulant circulant. Sang 1954;25:1–15.
Nilsson IM, Astedt B, Hedner U, et al. Intrauterine death and circulating anticoagulant (“antithromboplastin”). Acta Med Scand 1975;197:153–159.
Soulier JP, Boffa MC. Avortements a repetition thromboses et anticoagulant circulant anti-thromboplastine. Nouv Press Med 1980;9:859–864.
McIntyre JA, Wagenknecht DR. Antiphospholipid Antibodies: risk assessment for solid organ, bone marrow, and tissue transplantation. Rheum Dis Clin N Am 2001;27:611–631.
Sangle SR, D’Cruz DP, Khamashta MA, Hughes GRV. Antiphospholipid antibodies, systemic lupus erythematosus and non-traumatic metatarsal fractures. Ann Rheum Dis 2004;63:1241–1243.
Sangle SR, D’Cruz DP, Jan W, et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 2003;62:999–1002.
Sangle SR, Jan W, Lau IS, et al. Coeliac artery stenosis and antiphospholipid (Hughes) syndrome/antiphospholipid antibodies. Lupus 2005;14.
Hughes GRV. Migraine, memory loss, and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes) syndrome. Postgrad Med J 2003;79:81–83.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
Khamashta, M.A. (2006). Hughes Syndrome: History. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_1
Download citation
DOI: https://doi.org/10.1007/1-84628-009-5_1
Publisher Name: Springer, London
Print ISBN: 978-1-85233-873-2
Online ISBN: 978-1-84628-009-2
eBook Packages: MedicineMedicine (R0)
